NXSTAGE PUREFLOW SOLUTION DIN 02443279
Health Canada record
| Active ingredient(s) | SODIUM LACTATE 7.471 G; CALCIUM CHLORIDE 0.221 G; POTASSIUM CHLORIDE 0.075 G; MAGNESIUM CHLORIDE 0.102 G; SODIUM CHLORIDE 5.844 G; DEXTROSE 1.1 G |
|---|---|
| Dosage form | Solution |
| Route | Haemodialysis |
| Schedule | ETHICAL |
| Class | Human |
| ATC | B05ZA HEMODIALYTICS, CONCENTRATES |
| Original market date | 15-Sep-2016 |
| Current status date | 20-Feb-2026 |
| Source | Health Canada DPD |
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing SODIUM LACTATE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 00758566 | LACTATED RINGER'S IRRIGATION | ICU MEDICAL CANADA INC | Solution | SODIUM LACTATE 310 MG; SODIUM CHLORIDE 600 MG; POTASSIUM CHLORIDE 30 MG; CALCIUM CHLORIDE 20 MG | Marketed |
| 02363631 | NXSTAGE PUREFLOW DIALYSATE CONCENTRATE (SAK 304) | NXSTAGE MEDICAL INC | Solution | SODIUM LACTATE 176.5 G; SODIUM CHLORIDE 116.6 G; CALCIUM CHLORIDE 4.63 G; MAGNESIUM CHLORIDE 2.13 G; POTASSIUM CHLORIDE 3.14 G; DEXTROSE 23.1 G | Marketed |
| 02363615 | NXSTAGE PUREFLOW DIALYSATE CONCENTRATE (SAK-301) | NXSTAGE MEDICAL INC | Solution | SODIUM LACTATE 176.5 G; SODIUM CHLORIDE 116.6 G; CALCIUM CHLORIDE 4.63 G; MAGNESIUM CHLORIDE 2.13 G; POTASSIUM CHLORIDE 1.57 G; DEXTROSE 23.1 G | Marketed |
| 02363666 | NXSTAGE PUREFLOW DIALYSATE CONCENTRATE (SAK-302) | NXSTAGE MEDICAL INC | Solution | SODIUM LACTATE 156.88 G; SODIUM CHLORIDE 122.64 G; CALCIUM CHLORIDE 4.63 G; MAGNESIUM CHLORIDE 2.13 G; POTASSIUM CHLORIDE 1.57 G; DEXTROSE 23.1 G | Marketed |
| 02443287 | NXSTAGE PUREFLOW SOLUTION | NXSTAGE MEDICAL INC | Solution | SODIUM LACTATE 8.405 G; CALCIUM CHLORIDE 0.221 G; POTASSIUM CHLORIDE 0.075 G; MAGNESIUM CHLORIDE 0.102 G; SODIUM CHLORIDE 5.552 G; DEXTROSE 1.1 G | Marketed |
| 02443295 | NXSTAGE PUREFLOW SOLUTION | NXSTAGE MEDICAL INC | Solution | SODIUM LACTATE 8.405 G; CALCIUM CHLORIDE 0.221 G; POTASSIUM CHLORIDE 0.149 G; MAGNESIUM CHLORIDE 0.102 G; SODIUM CHLORIDE 5.552 G; DEXTROSE 1.1 G | Marketed |
| 02025507 | DELFLEX A PERITON.DIAL.SOLN.W.4.25% DEXTROSE | FRESENIUS USA MANUFACTURING INC | Solution | SODIUM LACTATE 392 MG; CALCIUM CHLORIDE 25.7 MG; MAGNESIUM CHLORIDE 15.2 MG; DEXTROSE 4.25 G; SODIUM CHLORIDE 567 MG | Cancelled Post Market |
| 01965018 | INPERSOL LC WITH DEXTROSE 2.5% LIQ | ABBOTT LABORATORIES, LIMITED | Liquid | SODIUM LACTATE 4.48 MG; SODIUM CHLORIDE 5.38 MG; CALCIUM CHLORIDE .184 MG; MAGNESIUM CHLORIDE .051 MG; DEXTROSE 25 MG | Cancelled Post Market |
| 01965026 | INPERSOL LC WITH DEXTROSE 4.25% LIQ | ABBOTT LABORATORIES, LIMITED | Liquid | SODIUM LACTATE 4.48 MG; SODIUM CHLORIDE 5.38 MG; CALCIUM CHLORIDE .184 MG; MAGNESIUM CHLORIDE .051 MG; DEXTROSE 42.5 MG | Cancelled Post Market |
| 00495697 | INPERSOL W DEXTROSE 4.25% INJ | ABBOTT LABORATORIES, LIMITED | Solution | SODIUM LACTATE 3.92 MG; SODIUM CHLORIDE 5.6 MG; CALCIUM CHLORIDE 0.26 MG; MAGNESIUM CHLORIDE 0.15 MG; DEXTROSE 42.5 MG | Cancelled Post Market |
| 00039306 | LACTATE 1-2-3 INJECTION | ICU MEDICAL CANADA INC | Solution | SODIUM LACTATE 3.1 MG; SODIUM CHLORIDE 3 MG; DEXTROSE 25 MG | Dormant |
| 02239533 | LACTATED RINGER'S INJECTION, USP | ABBOTT LABORATORIES, LIMITED | Liquid | SODIUM LACTATE 3.1 G; SODIUM CHLORIDE 6.0 G; POTASSIUM CHLORIDE 0.3 G; CALCIUM CHLORIDE 0.2 G; WATER 1 L | Cancelled Post Market |
| 02363623 | NXSTAGE PUREFLOW DIALYSATE CONCENTRATE (SAK 303) | NXSTAGE MEDICAL INC | Solution | SODIUM LACTATE 176.5 G; SODIUM CHLORIDE 116.6 G; CALCIUM CHLORIDE 4.63 G; MAGNESIUM CHLORIDE 2.13 G; POTASSIUM CHLORIDE 1.57 G; DEXTROSE 23.1 G | Dormant |
| 02363658 | NXSTAGE PUREFLOW DIALYSATE CONCENTRATE (SAK 305) | NXSTAGE MEDICAL INC | Solution | SODIUM LACTATE 176.5 G; SODIUM CHLORIDE 116.6 G; CALCIUM CHLORIDE 4.63 G; MAGNESIUM CHLORIDE 2.13 G; POTASSIUM CHLORIDE 1.57 G; DEXTROSE 23.1 G | Dormant |
International API supply for SODIUM LACTATE
5 active FDA Drug Master Files.
Request a quote for NXSTAGE PUREFLOW SOLUTION